Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT

Hormone and Metabolic Research

Volumn 34, Issue 5, 2002, Pages 229-233

  Zatelli, M C ^a   Tagliati, F ^a   Taylor, J E ^b   Piccin, D ^a   Culler, M D ^b   Degli Uberti, E C ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Biomeasure Inc   (United States)

Author keywords

Calcitonin Secretion; Gene Expression; Medullary Thyroid Carcinoma; Somatostatin; Somatostatin Receptors

Indexed keywords

ANGIOPEPTIN; BIM 23120; BIM 23206; CALCITONIN; OCTREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; DNA; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID MEDULLARY CARCINOMA; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; NORTHERN BLOTTING; THYROID TUMOR;

BLOTTING, NORTHERN; CALCITONIN; CELL COUNT; CELL DIVISION; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; HUMANS;

EID: 0035989072     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32134     Document Type: Article

References (26)

1. Somatostatin receptors and disease: Role of receptor subtypes
2. Somatostatin and its receptor family
3. Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells
4. A large family with hereditary MTC: Role of RET genetic analysis in differential diagnosis between MEN2A and FMTC
5. Regulatory peptides and other neuroendocrine markers in medullary thyroid carcinoma of the thyroid
6. Human medullary thyroid carcinoma in tissue culture: Secretion of calcitonin and carcinoembryonic antigen
7. Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma
8. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary thyroid carcinoma of the thyroid
9. Molecular weight forms of immunoreactive calcitonin in a patient with medullary carcinoma of the thyroid: Dynamic studies with calcium, pentagastrin and somatostatin
10. Slow release lanreotide in combination with Interferon-a2b in the treatment of symptomatic advanced medullary thyroid carcinoma
11. Current approaches and perspectives in the therapy of medullary thyroid carcinoma
12. Results of long term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma
13. Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon α-2b and octreotide
14. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT
15. Hybridocytochemical and immuno-ultrastructural study of calcitonin gene expression in cultured medullary carcinomas cells
16. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid stimulating hormone, and prolactin regulation
17. 3H-thymidine incorporation and c-myc, but not thyroglobulin ribonucleic acid levels in human thyroid follicular cells in vitro
18. Transforming growth factor-β 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels
19. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
20. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2
21. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1)
22. C-terminal region of human somatostatin receptor five is required for induction of Rb and Gi cell cycle arrest
23. Subtype selective induction of p53-dependent apoptosis but not cell cycle arrest by human somatostatin receptor 3
24. Regulation of human calcitonin gene transcription by cyclic AMP
25. Mechanisms of action of somatostatin: An overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins
26. Long-term exposure to SMS 201-995 inhibits proliferation and calcitonin release in neoplastic C-cells